The clinical management of COPD exacerbations: an update
TN Bonten, MJ Kasteleyn, C Taube… - Expert Review of …, 2016 - Taylor & Francis
Clinical management of chronic obstructive pulmonary disease (COPD) exacerbations is of
high importance because exacerbations reduce quality of life, increase mortality and carry …
high importance because exacerbations reduce quality of life, increase mortality and carry …
Exacerbations of COPD
Exacerbations of chronic obstructive pulmonary disease (COPD) are defined as sustained
worsening of a patient's condition beyond normal day-to-day variations that is acute in onset …
worsening of a patient's condition beyond normal day-to-day variations that is acute in onset …
Association between incidence of acute exacerbation and medication therapy in patients with COPD
DC Suh, H Lau, HO La, I Choi… - Current medical research …, 2010 - Taylor & Francis
Background: As exacerbations of chronic obstructive pulmonary disease (COPD)
significantly worsen patients' health status and increase disease-related mortality, greater …
significantly worsen patients' health status and increase disease-related mortality, greater …
Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
PMA Calverley, K Tetzlaff, D Dusser… - … journal of chronic …, 2017 - Taylor & Francis
Background Exacerbation history is used to grade the risk of COPD exacerbation, but its
reliability and relationship to other risk factors and prior therapy is unclear. To examine these …
reliability and relationship to other risk factors and prior therapy is unclear. To examine these …
Treatment of COPD exacerbations: pharmacologic options and modification of risk factors
AR Blanchard - Postgraduate medicine, 2002 - Taylor & Francis
PREVIEW Acute exacerbations of chronic obstructive pulmonary disease (COPD) pose a
continuing threat to quality and length of life in affected patients. As the prevalence of the …
continuing threat to quality and length of life in affected patients. As the prevalence of the …
COPD: early diagnosis and treatment to slow disease progression
T Welte, C Vogelmeier, A Papi - International journal of clinical …, 2015 - Wiley Online Library
Aims Chronic obstructive pulmonary disease (COPD) is usually a progressive condition.
Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become …
Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become …
Bringing stability to the chronic obstructive pulmonary disease patient: clinical and pharmacological considerations for frequent exacerbators
S Gulati, JM Wells - Drugs, 2017 - Springer
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are critical events
associated with an accelerated loss of lung function, increased morbidity, and excess …
associated with an accelerated loss of lung function, increased morbidity, and excess …
Managing exacerbations of COPD: how much progress have we made?
F Baraldi, M Barrecheguren, A Papi… - COPD in the 21st …, 2024 - books.google.com
The pharmacological treatment of exacerbations of COPD has not significantly changed in
the last decades. The use of short-acting bronchodilators to improve symptoms, systemic …
the last decades. The use of short-acting bronchodilators to improve symptoms, systemic …
Use of inhaled corticosteroids in COPD: improving efficacy
IA Yang, JG Shaw, JR Goddard… - Expert review of …, 2016 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a chronic, inflammatory lung disease
characterized by airflow limitation that is not fully reversible. The pathological changes in …
characterized by airflow limitation that is not fully reversible. The pathological changes in …
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
While the pharmacological management of chronic obstructive pulmonary disease (COPD)
has evolved from the drugs used to treat asthma, the treatment models are different and the …
has evolved from the drugs used to treat asthma, the treatment models are different and the …